Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism HSV antigen inhibitors(herpes simplex virus antigen inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC17H22ClN5O4S2 |
InChIKeyZHUSYZGGEMQUHH-UHFFFAOYSA-N |
CAS Registry292136-38-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Herpes Simplex | Discovery | DE | 06 Oct 2022 |